Home
Lotus Eye Hospital & Institute Ltd Board of Directors
Board of Directors at Lotus Eye Hospital & Institute Ltd
D Kaarthikeyan
Independent Director
K Ramalaingam
Additional Director
Karthik Veeramani
Additional Director
Kaveetha Sundaramoorthy
Chairman
M menon
Company Secretary
Key Highlights
- Sangeetha Sundaramoorthy joins the board as ED / MD / Promoter, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Kaveetha Sundaramoorthy joins the board as Chairman & Non Executive Dir., in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- K.S. Ramalingam joins the board as Executive Director / Whole Time Director / CEO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- S Natesan joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Karthik Veeramani joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Lotus Eye Hospital & Institute Ltd
NSE: LOTUSEYE
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 18 Dec 2025 | 127 |
| 17 Dec 2025 | 133.3 |
| 16 Dec 2025 | 129.3 |
| 15 Dec 2025 | 131.25 |
| 12 Dec 2025 | 128.4 |
| 11 Dec 2025 | 118.95 |
| 10 Dec 2025 | 112.8 |
| 09 Dec 2025 | 111.5 |
| 08 Dec 2025 | 103.05 |
| 04 Dec 2025 | 105.2 |
Company Fundamentals for Lotus Eye Hospital & Institute Ltd
Market Cap
264 Cr
EPS
0.3
P/E Ratio (TTM)
396.9
P/B Ratio (TTM)
4.4
Day’s High
137.8
Day’s Low
126.9
DTE
0.1
ROE
1.1
52 Week High
140.9
52 Week Low
55.31
ROCE
2.6
Market Price of Lotus Eye Hospital & Institute Ltd
1M
1Y
3Y
5Y
Monitoring Lotus Eye Hospital & Institute Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Lotus Eye Hospital & Institute Ltd News Hub
Lotus Eye Hospital & Institute standalone net profit declines 55.07% in the June 2024 quarter
Net profit of Lotus Eye Hospital & Institute declined 55.07% to Rs 0.62 crore in the quarter ended J
Read more
13 Aug 24
Lotus Eye Hospital & Institute to discuss results
Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 12 No
Read more
04 Nov 24
Lotus Eye Hospital & Institute standalone net profit declines 88.24% in the September 2024 quarter
Net profit of Lotus Eye Hospital & Institute declined 88.24% to Rs 0.10 crore in the quarter ended S
Read more
13 Nov 24
Lotus Eye Hospital & Institute Ltd leads gainers in 'B' group
Country Condos Ltd, Hexa Tradex Ltd, Jagsonpal Pharmaceuticals Ltd and SEL Manufacturing Company Ltd
Read more
25 Apr 25
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Lotus Eye Hospital & Institute Ltd
How are members of Lotus Eye Hospital & Institute Ltd Board of Directors selected?
Members of the Lotus Eye Hospital & Institute Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Lotus Eye Hospital & Institute Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Lotus Eye Hospital & Institute Ltd Board of Directors?
Shareholders can interact with the Lotus Eye Hospital & Institute Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Lotus Eye Hospital & Institute Ltd Board of Directors meet?
The Lotus Eye Hospital & Institute Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Lotus Eye Hospital & Institute Ltd Board of Directors?
The Lotus Eye Hospital & Institute Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Lotus Eye Hospital & Institute Ltd?
The current Board of Directors at Lotus Eye Hospital & Institute Ltd includes Sangeetha Sundaramoorthy( ED / MD / Promoter) ,Kaveetha Sundaramoorthy( Chairman & Non Executive Dir.) ,K.S. Ramalingam( Executive Director / Whole Time Director / CEO) ,S Natesan( Independent Non Exe. Director) ,Karthik Veeramani( Independent Non Exe. Director) . The full list can be found on Lotus Eye Hospital & Institute Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
